Cancer and cardiovascular disease

• Published in: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis Vol. 27; no. 5; p. 221
• Main Authors: Lahoz, Carlos, Valdivielso, Pedro, González-Alegre, María Teresa, García-Iglesias, María Francisca, Estirado, Eva, Mostaza, José M
• Format: Journal Article
• Language: Spanish
• Published: Spain 01.09.2015
• Subjects: Antineoplastic Agents - adverse effects; Antineoplastic Agents - therapeutic use; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - etiology; Cardiovascular Diseases - prevention & control; Hematopoietic Stem Cell Transplantation - adverse effects; Hematopoietic Stem Cell Transplantation - methods; Humans; Life Style; Metabolic Syndrome - complications; Metabolic Syndrome - epidemiology; Metabolic Syndrome - etiology; Neoplasms - therapy; Risk Factors; Survival Rate; Survivors; Cardiovascular disease; Transplantation of hematopoietic cells; Transplante de células hematopoyéticas; Cancer; Enfermedad cardiovascular
• ISSN: 1578-1879
• DOI: 10.1016/j.arteri.2015.02.002

Survivors of cancer have a shorter survival in the long term partly due to the increase in cardiovascular diseases (CVD). Some chemotherapy drugs, thoracic and cranial radiotherapy and above all the transplantation of hematopoietic cells are associated with an increase in the incidence of cardiovascular events compared with general population. Some of these treatments favor the development of a metabolic syndrome that could be the intermediary between these treatments and the development of CVD. It is recommended for cancer survivors to promote healthy lifestyles and the strict control of cardiovascular risk factors.